NO992273D0 - Anvendelse av et promedikament med en struktur svarende til den av en biopÕvirkende forbindelse som er et uracil eller en uracilbaseanalog - Google Patents
Anvendelse av et promedikament med en struktur svarende til den av en biopÕvirkende forbindelse som er et uracil eller en uracilbaseanalogInfo
- Publication number
- NO992273D0 NO992273D0 NO992273A NO992273A NO992273D0 NO 992273 D0 NO992273 D0 NO 992273D0 NO 992273 A NO992273 A NO 992273A NO 992273 A NO992273 A NO 992273A NO 992273 D0 NO992273 D0 NO 992273D0
- Authority
- NO
- Norway
- Prior art keywords
- uracil
- prodrug
- structure similar
- bioactive compound
- base analogue
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70146291A | 1991-05-15 | 1991-05-15 | |
US82947492A | 1992-02-03 | 1992-02-03 | |
PCT/US1992/004142 WO1992020816A1 (en) | 1991-05-15 | 1992-05-15 | Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO992273D0 true NO992273D0 (no) | 1999-05-11 |
NO992273L NO992273L (no) | 1999-05-11 |
NO308884B1 NO308884B1 (no) | 2000-11-13 |
Family
ID=27106792
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934059A NO306850B1 (no) | 1991-05-15 | 1993-11-09 | Anvendelse av 5-halo-2-pyrimidinon-deoksyribose eller 5-halo-2-pyrimidinon for fremstilling av et medikament for behandling av leversykdom |
NO992273A NO308884B1 (no) | 1991-05-15 | 1999-05-11 | Anvendelse av 5-halo-2-pyrimidin-deoksyribose eller 5-halo- pyrimidinon for fremstilling av et medikament for behandling av kreft |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934059A NO306850B1 (no) | 1991-05-15 | 1993-11-09 | Anvendelse av 5-halo-2-pyrimidinon-deoksyribose eller 5-halo-2-pyrimidinon for fremstilling av et medikament for behandling av leversykdom |
Country Status (13)
Country | Link |
---|---|
US (1) | US5728684A (no) |
EP (1) | EP0586523A4 (no) |
JP (1) | JPH06507902A (no) |
KR (1) | KR100245252B1 (no) |
AU (1) | AU673803B2 (no) |
BG (1) | BG98217A (no) |
CA (1) | CA2103050A1 (no) |
HU (1) | HUT67392A (no) |
IE (1) | IE921581A1 (no) |
IL (1) | IL101879A (no) |
NO (2) | NO306850B1 (no) |
RU (1) | RU2126255C1 (no) |
WO (1) | WO1992020816A1 (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9600847D0 (en) | 1996-01-16 | 1996-03-20 | Smithkline Beecham Plc | Pharmaceuticals |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
CA2343522A1 (en) * | 1998-09-04 | 2000-03-16 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
US6818227B1 (en) | 1999-02-08 | 2004-11-16 | Alza Corporation | Liposome composition and method for administration of a radiosensitizer |
ATE306489T1 (de) | 1999-03-08 | 2005-10-15 | Medicure Inc | Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel |
WO2001003745A2 (en) * | 1999-07-09 | 2001-01-18 | Board Of Regents Of University Of Nebraska | Therapy and diagnosis of colorectal cancer with radiopharmaceuticals |
CA2376029A1 (en) * | 1999-07-13 | 2001-01-18 | Medicure Inc. | Use of pyridoxin derivatives for the treatment of diabetes and related complications |
JP2003507418A (ja) * | 1999-08-24 | 2003-02-25 | メディキュア インターナショナル インコーポレイテッド | 心血管疾患とその関連疾患の治療 |
WO2001064692A1 (en) | 2000-02-29 | 2001-09-07 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US6586414B2 (en) | 2000-03-28 | 2003-07-01 | Medicure International Inc. | Treatment of cerebrovascular disease |
AU2001272263B2 (en) | 2000-07-07 | 2005-12-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
AU2002322805B2 (en) * | 2001-07-31 | 2007-11-08 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Inhibitor of DNA methylation |
US7015022B2 (en) * | 2002-06-07 | 2006-03-21 | University Of Medicine & Dentistry Of New Jersey | Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities |
US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
US20060019929A1 (en) * | 2004-07-07 | 2006-01-26 | Albert Friesen | Combination therapies employing platelet aggregation drugs |
US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
CA2585165A1 (en) * | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
EA015252B1 (ru) | 2005-05-10 | 2011-06-30 | Интермьюн, Инк. | Способ модуляции стресс-активированной протеинкиназной системы |
WO2007059631A1 (en) * | 2005-11-28 | 2007-05-31 | Medicure International Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
CN102099036B (zh) | 2008-06-03 | 2015-05-27 | 英特芒尼公司 | 用于治疗炎性疾患和纤维化疾患的化合物和方法 |
JP2012521359A (ja) * | 2009-03-20 | 2012-09-13 | アリオス バイオファーマ インク. | 置換されたヌクレオシドアナログおよびヌクレオチドアナログ |
GEP20156313B (en) | 2010-09-22 | 2015-07-10 | Alios Biopharma Inc | Substituted nucleotide analogs |
EP2794630A4 (en) | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE |
CN104321333A (zh) | 2012-03-21 | 2015-01-28 | 沃泰克斯药物股份有限公司 | 硫代氨基磷酸酯核苷酸前药的固体形式 |
WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
RU2522548C2 (ru) * | 2012-09-26 | 2014-07-20 | Федеральное государственное бюджетное учреждение науки Институт кристаллографии им. А.В. Шубникова Российской академии наук (ИК РАН) | Ингибитор уридинфосфорилаз |
RU2527457C2 (ru) * | 2012-09-27 | 2014-08-27 | Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) | Ингибиторы поли(адф-рибозо)полимеразы-1 человека на основе производных урацила |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CN110452216B (zh) | 2014-04-02 | 2022-08-26 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
WO2016057699A1 (en) | 2014-10-07 | 2016-04-14 | Kinsella Timothy J | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER WITH 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE (IPdR) |
EP3565557A4 (en) | 2017-01-09 | 2020-12-02 | Shuttle Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS FOR ANTI-CANCER THERAPIES INCLUDING THE ADMINISTRATION OF HALOGENATED THYMIDINES AND THYMIDINE PHOSPHORYLASE INHIBITORS IN COMBINATION WITH RADIATION |
WO2018148580A1 (en) * | 2017-02-09 | 2018-08-16 | Perfect Daylight Limited | Methods for autism spectrum disorder pharmacotherapy |
EP4003508A1 (en) | 2019-07-31 | 2022-06-01 | Memorial Sloan Kettering Cancer Center | Perfusion modulated tumor dose sculpting with single dose radiotherapy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895937A (en) * | 1982-01-05 | 1990-01-23 | The Research Foundation Of State University Of New York | 5-ioso-2-pyrimidinone nucleoside |
US4782142A (en) * | 1982-01-05 | 1988-11-01 | The Research Foundation Of State University Of New York | Novel 5-substituted 2-pyrimidinone nucleosides and methods of use |
US4468384A (en) * | 1982-01-05 | 1984-08-28 | The Research Foundation Of State University Of New York | Method for the inhibition of the replication of DNA viruses with 5-substituted 2-pyrimidinone nucleosides |
NZ223880A (en) * | 1987-03-16 | 1991-06-25 | Wellcome Found | 1-(3-azido-2,3-dideoxy-alpha-d-erythro-pentofuranosyl)-5- methyl-2(1h)-pyrimidinone and pharmaceutically acceptable derivatives thereof and methods of preparation |
US4942226A (en) * | 1988-12-29 | 1990-07-17 | Merck & Co., Inc. | Halogenated pyrimidine nucleosides and their derivatives |
EP0711555A2 (en) * | 1990-07-19 | 1996-05-15 | The Wellcome Foundation Limited | Enzyme inactivators |
GB9020930D0 (en) * | 1990-09-26 | 1990-11-07 | Wellcome Found | Pharmaceutical combinations |
-
1992
- 1992-05-15 WO PCT/US1992/004142 patent/WO1992020816A1/en active Application Filing
- 1992-05-15 EP EP92912221A patent/EP0586523A4/en not_active Withdrawn
- 1992-05-15 IL IL101879A patent/IL101879A/en not_active IP Right Cessation
- 1992-05-15 CA CA002103050A patent/CA2103050A1/en not_active Abandoned
- 1992-05-15 JP JP5500240A patent/JPH06507902A/ja not_active Abandoned
- 1992-05-15 RU RU93058654A patent/RU2126255C1/ru active
- 1992-05-15 AU AU19982/92A patent/AU673803B2/en not_active Ceased
- 1992-05-15 KR KR1019930703451A patent/KR100245252B1/ko not_active IP Right Cessation
- 1992-05-15 US US08/146,164 patent/US5728684A/en not_active Expired - Fee Related
- 1992-05-15 HU HU9303237A patent/HUT67392A/hu unknown
- 1992-07-01 IE IE158192A patent/IE921581A1/en not_active Application Discontinuation
-
1993
- 1993-11-09 NO NO934059A patent/NO306850B1/no not_active IP Right Cessation
- 1993-11-12 BG BG98217A patent/BG98217A/bg unknown
-
1999
- 1999-05-11 NO NO992273A patent/NO308884B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2126255C1 (ru) | 1999-02-20 |
BG98217A (bg) | 1995-02-28 |
NO934059D0 (no) | 1993-11-09 |
EP0586523A4 (en) | 1995-11-29 |
JPH06507902A (ja) | 1994-09-08 |
IE921581A1 (en) | 1992-11-18 |
NO934059L (no) | 1993-12-30 |
US5728684A (en) | 1998-03-17 |
WO1992020816A1 (en) | 1992-11-26 |
HU9303237D0 (en) | 1994-03-28 |
HUT67392A (en) | 1995-04-28 |
EP0586523A1 (en) | 1994-03-16 |
KR100245252B1 (ko) | 2000-03-02 |
IL101879A0 (en) | 1992-12-30 |
CA2103050A1 (en) | 1992-11-16 |
NO308884B1 (no) | 2000-11-13 |
AU673803B2 (en) | 1996-11-28 |
NO306850B1 (no) | 2000-01-03 |
AU1998292A (en) | 1992-12-30 |
IL101879A (en) | 1998-06-15 |
NO992273L (no) | 1999-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992273D0 (no) | Anvendelse av et promedikament med en struktur svarende til den av en biopÕvirkende forbindelse som er et uracil eller en uracilbaseanalog | |
NO170260C (no) | Fremstilling av oksygen med hoey renhet | |
MX9204474A (es) | Analogos nucleosidos 1,3-oxatiolano. | |
NO168423C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive bis-(hydroksymetyl) -cyklobutylpuriner og -pyrimidiner | |
NO172986C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 9h-puriner | |
DK250089D0 (da) | Immunstimulerende 7-deaza-7-oxa- og 7-deaza-7-thia-analoge af 8-substituerede guanin-9-(1'-beta-d-aldoglycosidyl)-derivater samt deres anvendelse | |
FI923497A (fi) | Roterande anslutning med laonglivad taetning | |
IT1231521B (it) | Impiego in terapeutica di analoghi o di derivati della somatostatina | |
NO920082D0 (no) | Fremgangsmaate for forbehandling av lignocellulosematerialer foer hoeyutbytte- massedannelse med alkali-peroksyd | |
DK282187A (da) | Forstoever med tilfoersel af hjaelpeluft | |
DK420185D0 (da) | Anvendelse af somatostatinanaloge | |
FI881821A0 (fi) | Nya supraledande kopparoxidfoereningar med skiktstruktur. | |
NO922801D0 (no) | Fremgangsmaate til fremstilling av suksinylkolinhalogenider | |
NO168586C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser | |
FR2620441B1 (fr) | Renovation du marbre exterieur | |
DK501788A (da) | Anvendelse af visse 6-mercaptopuriner til fremstilling af laegemidler | |
IT8940187A0 (it) | Sostegno regolabile per fissare appendere qualsiasi tipo di tendaggio o altri oggetti alle pareti. | |
GB8811329D0 (en) | Improvements relating to attachment of curtain supports to lintels | |
FI92853C (fi) | Rakennuksen porrastilan nousujohtokanava | |
IT8809390A0 (it) | Occlusore atto ad ottenere due immagini delle arcate dentarie perfettamente sovrapponibili | |
IT89029003U1 (it) | Sostegno regolabile per fissare appendere qualsiasi tipo di tendaggio e altri oggetti alle pareti. | |
LV5499A3 (lv) | 2-Tieniloksietikskabes atvasinajumu vai to farmaceitiski pienemamu salu iegusanas panemiens | |
ITVR910097A0 (it) | Kit comprendente mezzi e materiali per il risanamento di murature o similari soggette al fenomeno dell'umidita' ascendente e procedimento di attuazione | |
IT1289620B1 (it) | Analoghi delle purine atti all'inibizione dell'angiogenesi | |
ITPD910097U1 (it) | Struttura di piastrella per pavimentazioni |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2001 |